Jane Street Group, LLC Denali Therapeutics Inc. Put Options Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$20.96 - $31.05 $391,952 - $580,635
18,700 New
18,700 $544,000
Q1 2022

May 17, 2022
SELL
$29.0 - $47.27 $710,500 - $1.16 Million
-24,500 Closed
0 $0
Q4 2021

Feb 15, 2022
BUY
$42.59 - $55.02 $1.04 Million - $1.35 Million
24,500 New
24,500 $1.09 Million

Others Institutions Holding DNLI

# of Institutions
228
Shares Held
120M
Call Options Held
60.6K
Put Options Held
48.4K
View Full List

About Denali Therapeutics Inc.

DNLI Quotes by TradingView
  • Ticker DNLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 134,174,000
  • Market Cap $3.38B
  • Description
  • Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...
More about DNLI
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email